Maxcyte

MXCT · LSE-AIM🇺🇸

Overview

Earnings Dividends Seasonality Metrics

Reported earnings 7 days ago

Total Revenue

$8.51M

Previous year: $10.4M

-18.4%

EPS

-$0.12

Previous year: -$0.09

+33.3%

Core Business Revenue Growth

8%

Installed Base of Instruments

814

Previous year: 723

+12.6%

Core Revenue from SPL Clients %

Previous year: $8.94M

-21.8%

Cash and Equivalents

$15.2M

Previous year: $37.5M

Loading...

Maxcyte

Unlock previous datapoints

Upgrade

Maxcyte

Unlock previous datapoints

Upgrade

Maxcyte Revenue by Segment

Revenue by Segment

Instruments Revenue

CapyFin.com

PAs and consumables Revenue

CapyFin.com

Licenses Revenue

CapyFin.com

Assay services Revenue

CapyFin.com

Other Revenue

CapyFin.com

Program-Related Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$501M

P/E Ratio

-382.35

Sector

N/A

Industry

N/A

52-Week High

$206

52-Week Low

$155

Core Business Revenue Growth

8%

Installed Base of Instruments

814

Core Revenue from SPL Clients %

42%

Number of Active SPLs

31

Gross Margin

82%

Products

Get in Touch

Resources

Maxcyte

Maxcyte

Maxcyte

Maxcyte Revenue by Segment

Revenue by Segment

Instruments Revenue

PAs and consumables Revenue

Licenses Revenue

Assay services Revenue

Other Revenue

Program-Related Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics